Sécalip

Sécalip may be available in the countries listed below.

Ingredient matches for Sécalip

Fenofibrate

Fenofibrate is reported as an ingredient of Sécalip in the following countries:

• France

International Drug Name Search

Amlodipine Arrow

Amlodipine Arrow may be available in the countries listed below.

Ingredient matches for Amlodipine Arrow

Amlodipine

Amlodipine is reported as an ingredient of Amlodipine Arrow in the following countries:

• Poland

Amlodipine besilate (a derivative of Amlodipine) is reported as an ingredient of Amlodipine Arrow in the following countries:

• France

Amlodipine maleate (a derivative of Amlodipine) is reported as an ingredient of Amlodipine Arrow in the following countries:

• Netherlands

International Drug Name Search

Acide gadopentétique

Acide gadopentétique may be available in the countries listed below.

Ingredient matches for Acide gadopentétique

Gadopentetic Acid

Acide gadopentétique (DCF) is also known as Gadopentetic Acid (Rec.INN)

International Drug Name Search

Glossary

DCF	Dénomination Commune Française
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Tiapride Fudan Fuhua

Tiapride Fudan Fuhua may be available in the countries listed below.

Ingredient matches for Tiapride Fudan Fuhua

Tiapride

Tiapride hydrochloride (a derivative of Tiapride) is reported as an ingredient of Tiapride Fudan Fuhua in the following countries:

• China

International Drug Name Search

Desquam-X Wash

Generic Name: benzoyl peroxide topical (BEN zoyl per OX ide)

Brand Names: Acne Treatment, Acne-Clear, Benzac AC, Benzac W, Benzashave 10, Benzashave 5, BenzEFoam, Benziq, Benziq Wash, BPO Foaming Cloths, Brevoxyl, Brevoxyl Acne Wash Kit, Brevoxyl-4 Creamy Wash Complete Pack, Brevoxyl-8 Creamy Wash Complete Pack, Breze, Clearplex, Clearskin, Clinac BPO, Desquam-E, Desquam-X 10, Desquam-X 5, Desquam-X Wash, Fostex Bar 10%, Fostex Gel 10%, Fostex Wash 10%, Inova, Lavoclen-4, Lavoclen-8, Loroxide, NeoBenz Micro, Neutrogena Acne Mask, Neutrogena On Spot Acne Treatment, Oscion, Oscion Cleanser, Oxy 10 Balance, Oxy Balance, Oxy Daily Wash Chill Factor, Oxy-10, Pacnex, PanOxyl, Panoxyl 10, Panoxyl 5, Panoxyl Aqua Gel, PanOxyl Maximum Strength Foaming Acne Wash, Persa-Gel, Seba-Gel, SoluCLENZ Rx, Triaz, Triaz Cleanser, Zaclir

What is Desquam-X Wash (benzoyl peroxide topical)?

Benzoyl peroxide has an antibacterial effect. It also has a mild drying effect, which allows excess oils and dirt to be easily washed away from the skin.

Benzoyl peroxide topical (for the skin) is used to treat acne.

Benzoyl peroxide topical may also be used for purposes not listed in this medication guide.

What is the most important information I should know about Desquam-X Wash (benzoyl peroxide topical)?

There are many brands and forms of benzoyl peroxide available and not all brands are listed on this leaflet.

Do not use benzoyl peroxide topical while you are also using tretinoin (Altinac, Avita, Renova, Retin-A, Tretin-X). Using these medications together could cause severe skin irritation.

Use this medication exactly as directed on the label, or as prescribed by your doctor. Do not use it in larger amounts or for longer than recommended.

Avoid getting this medication in your mouth or eyes. If it does get into any of these areas, rinse with water. Do not use benzoyl peroxide topical on sunburned, windburned, dry, chapped, irritated, or broken skin. Also avoid using benzoyl peroxide topical on wounds or on areas of eczema. Wait until these conditions have healed before using this medication.

Avoid using skin products that can cause irritation, such as harsh soaps, shampoos, or skin cleansers, hair coloring or permanent chemicals, hair removers or waxes, or skin products with alcohol, spices, astringents, or lime. Do not use other medicated skin products unless your doctor has told you to.

Benzoyl peroxide may bleach hair or fabrics. Avoid allowing this medication to come into contact with your hair or clothing.

It may take several weeks before your symptoms improve. Keep using the medication as directed and tell your doctor if your symptoms do not improve.

What should I discuss with my healthcare provider before using Desquam-X Wash (benzoyl peroxide topical)?

Do not use benzoyl peroxide topical while you are also using tretinoin (Altinac, Avita, Renova, Retin-A, Tretin-X). Using these medications together could cause severe skin irritation. FDA pregnancy category C. It is not known whether benzoyl peroxide topical will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication. It is not known whether benzoyl peroxide passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

How should I use Desquam-X Wash (benzoyl peroxide topical)?

Use exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended.

Wash your hands before and after applying this medication. Shake the lotion well just before each use.

Clean and pat dry the skin to be treated. Apply benzoyl peroxide in a thin layer and rub in gently.

Do not cover the treated skin area unless your doctor has told you to.

Benzoyl peroxide topical is usually applied one to three times daily. Follow your doctor's instructions.

Benzoyl peroxide may bleach hair or fabrics. Avoid allowing this medication to come into contact with your hair or clothing.

It may take several weeks before your symptoms improve. Keep using the medication as directed and tell your doctor if your symptoms do not improve.

Store at room temperature away from moisture and heat.

What happens if I miss a dose?

Use the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not use extra medicine to make up the missed dose.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while using Desquam-X Wash (benzoyl peroxide topical)?

Avoid getting this medication in your mouth or eyes. If it does get into any of these areas, rinse with water. Do not use benzoyl peroxide topical on sunburned, windburned, dry, chapped, irritated, or broken skin. Also avoid using benzoyl peroxide topical on wounds or on areas of eczema. Wait until these conditions have healed before using this medication.

Avoid using skin products that can cause irritation, such as harsh soaps, shampoos, or skin cleansers, hair coloring or permanent chemicals, hair removers or waxes, or skin products with alcohol, spices, astringents, or lime. Do not use other medicated skin products unless your doctor has told you to.

Avoid using sunscreen containing PABA on the same skin treated with benzoyl peroxide, or skin discoloration may occur.

Desquam-X Wash (benzoyl peroxide topical) side effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using benzoyl peroxide and call your doctor at once if you have severe stinging or burning of your skin.

Less serious side effects may include:

• 
  

  mild stinging or burning;

  
  


• 
  

  itching or tingly feeling;

  
  


• 
  

  skin dryness, peeling, or flaking; or

  
  


• 
  

  redness or other irritation.

  
  

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect Desquam-X Wash (benzoyl peroxide topical)?

It is not likely that other drugs you take orally or inject will have an effect on topically applied benzoyl peroxide topical. But many drugs can interact with each other. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.

More Desquam-X Wash resources

• Desquam-X Wash Side Effects (in more detail)
• Desquam-X Wash Use in Pregnancy & Breastfeeding
• Desquam-X Wash Drug Interactions
• Desquam-X Wash Support Group
• 1 Review for Desquam-X - Add your own review/rating

• Desquam-X Wash Prescribing Information (FDA)


• Acne Treatment Cream MedFacts Consumer Leaflet (Wolters Kluwer)


• BenzEFoam Foam MedFacts Consumer Leaflet (Wolters Kluwer)


• Benzac Topical Advanced Consumer (Micromedex) - Includes Dosage Information


• Benzac AC Wash MedFacts Consumer Leaflet (Wolters Kluwer)


• Benzefoam Prescribing Information (FDA)


• Benzefoam Ultra Prescribing Information (FDA)


• Brevoxyl Gel MedFacts Consumer Leaflet (Wolters Kluwer)


• Brevoxyl Creamy Wash Prescribing Information (FDA)


• Inova Pads MedFacts Consumer Leaflet (Wolters Kluwer)


• NeoBenz Micro Wash Plus Pack Cream MedFacts Consumer Leaflet (Wolters Kluwer)


• Neobenz Micro SD Prescribing Information (FDA)


• Neobenz Micro Wash Plus Pack Prescribing Information (FDA)


• Oxy Balance Topical Advanced Consumer (Micromedex) - Includes Dosage Information


• Pacnex LP Prescribing Information (FDA)


• PanOxyl Bar MedFacts Consumer Leaflet (Wolters Kluwer)


• Triaz Cloths MedFacts Consumer Leaflet (Wolters Kluwer)


• Triazolam Monograph (AHFS DI)

Compare Desquam-X Wash with other medications

• Acne
• Perioral Dermatitis

Where can I get more information?

• Your pharmacist can provide more information about benzoyl peroxide topical.

See also: Desquam-X side effects (in more detail)

Epioftal

Epioftal may be available in the countries listed below.

Ingredient matches for Epioftal

Epinastine

Epinastine is reported as an ingredient of Epioftal in the following countries:

• Peru

International Drug Name Search

Evamist

Evamist is a brand name of estradiol, approved by the FDA in the following formulation(s):

EVAMIST (estradiol - spray; transdermal)

• 
  Manufacturer: KV PHARM
  
  Approval date: July 27, 2007
  
  Strength(s): 1.53MG/SPRAY ^[RLD]

Has a generic version of Evamist been approved?

No. There is currently no therapeutically equivalent version of Evamist available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Evamist. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Dermal penetration enhancers and drug delivery systems involving same
  Patent 6,299,900
  Issued: October 9, 2001
  Inventor(s): Reed; Barry Leonard & Morgan; Timothy Matthias & Finnin; Barrie Charles
  Assignee(s): Monash University
  A transdermal drug delivery system which comprises at least one physiologically active agent or prodrug thereof and at least one dermal penetration enhancer; characterized in that the dermal penetration enhancer is a safe skin-tolerant ester sunscreen. A non-occlusive, percutaneous or transdermal drug delivery system which comprises: (i) an effective amount of at least one physiologically active agent or prodrug thereof; (ii) at least one non-volatile dermal penetration enhancer; and (iii) at least one volatile liquid; characterised in that the dermal penetration enhancer is adapted to transport the physiologically active agent across a dermal surface or mucosal membrane of an animal, including a human, when the volatile liquid evaporates, to form a reservoir or depot of a mixture comprising the penetration enhancer and the physiologically active agent or prodrug within said surface or membrane; and the dermal penetration enhancer is of low toxicity to, and is tolerated by, the dermal surface or mucosal membrane of the animal.
  
  Patent expiration dates:
  
  
  • February 19, 2017
    
    ✓ 
    Patent use: MENOPAUSAL AND POSTMENOPAUSAL DISORDERS (INCLUDING VASOMOTOR SYMPTOMS ASSOCCIATED WITH MENOPAUSE)
    ✓ 
    Drug product
  
  
  
  • February 19, 2017
    
    ✓ 
    Patent use: FEMALE HORMONE REPLACEMENT THERAPY FOR POSTMENOPAUSAL WOMEN
    ✓ 
    Drug product
  
  



• 
  Dermal penetration enhancers and drug delivery systems involving same
  Patent 6,818,226
  Issued: November 16, 2004
  Inventor(s): Barry Leonard; Reed & Timothy Matthias; Morgan & Barrie Charles; Finnin
  Assignee(s): ACRUX DDS Pty. Ltd.
  A transdermal drug delivery system which comprises at least one physiologically active agent or prodrug thereof and at least one dermal penetration enhancer; characterised in that the dermal penetration enhancer is a safe skin-tolerant ester sunscreen. A non-occlusive, percutaneous or transdermal drug delivery system which comprises: (i) an effective amount of at least one physiologically active agent or prodrug thereof; (ii) at least one non-volatile dermal penetration enhancer; and (iii) at least one volatile liquid; characterised in that the dermal penetration enhancer is adapted to transport the physiologically active agent across a dermal surface or mucosal membrane of an animal, including a human, when the volatile liquid evaporates, to form a reservoir or depot of a mixture comprising the penetration enhancer and the physiologically active agent or prodrug within said surface or membrane; and the dermal penetration enhancer is of low toxicity to, and is tolerated by, the dermal surface or mucosal membrane of the animal.
  
  Patent expiration dates:
  
  
  • February 19, 2017
    
    ✓ 
    Patent use: FEMALE HORMONE REPLACEMENT THERAPY FOR POSTMENOPAUSAL WOMEN
    ✓ 
    Drug product
  
  
  
  • February 19, 2017
    
    ✓ 
    Patent use: MENOPAUSAL AND POSTMENOPAUSAL DISORDERS (INCLUDING VASOMOTOR SYMPTOMS ASSOCCIATED WITH MENOPAUSE)
    ✓ 
    Drug product
  
  



• 
  Transdermal delivery of hormones
  Patent 6,923,983
  Issued: August 2, 2005
  Inventor(s): Morgan; Timothy Matthias & Bakalova; Margarita Vladislavova & Klose; Karthryn Traci-Jane & Finnin; Barrie Charles & Reed; Barry Leonard
  Assignee(s): Acrux DDS PTY LTD
  The present invention provides a transdermal drug delivery system which comprises: a therapeutically effective amount of a hormone; at least one dermal penetration enhancer, which is a safe skin-tolerant ester sunscreen ester; and at least one volatile liquid. The invention also provides a method for administering at least one systemic acting hormone to an animal which comprises applying an effective amount of the hormone in the form of the drug delivery system of the present invention
  
  Patent expiration dates:
  
  
  • February 19, 2017
    
    ✓ 
    Patent use: MENOPAUSAL AND POSTMENOPAUSAL DISORDERS (INCLUDING VASOMOTOR SYMPTOMS ASSOCCIATED WITH MENOPAUSE)
    ✓ 
    Drug product
  
  
  
  • February 19, 2017
    
    ✓ 
    Patent use: FEMALE HORMONE REPLACEMENT THERAPY FOR POSTMENOPAUSAL WOMEN
    ✓ 
    Drug product
  
  



• 
  Dispensing device
  Patent 6,978,945
  Issued: December 27, 2005
  Inventor(s): Wong; Kon Euan & Bayly; Mark Simon
  Assignee(s): Acrux DDS Pty Ltd
  Hand-held dispensing devices for dispensing and applying a substance to the skin of a host are described. The devices include a hollow body, a capsule mounted within the hollow body for containing the substance, a nozzle mounted within the hollow body communicating with the substance in the capsule, an actuator to cause metered quantities of the substance to be dispensed from the capsule through the nozzle, a shroud defining an exit space for receiving the substance emerging from the nozzle, and a cap detachably mounted on the shroud to selectively open and close the nozzle and thereby control escape of the substance from the capsule.
  
  Patent expiration dates:
  
  
  • November 30, 2021
    
    ✓ 
    Drug product
  
  

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • July 27, 2010 - NEW DOSAGE FORM
  
  

See also...

• Evamist Consumer Information (Drugs.com)
• Evamist Spray Consumer Information (Wolters Kluwer)
• Evamist for use on skin Consumer Information (Cerner Multum)
• Estradiol Consumer Information (Drugs.com)
• Estradiol Consumer Information (Wolters Kluwer)
• Estradiol Acetate Consumer Information (Wolters Kluwer)
• Estradiol Cypionate Consumer Information (Wolters Kluwer)
• Estradiol Gel Consumer Information (Wolters Kluwer)
• Estradiol Gel Packets Consumer Information (Wolters Kluwer)
• Estradiol Patch Consumer Information (Wolters Kluwer)
• Estradiol Ring Consumer Information (Wolters Kluwer)
• Estradiol Spray Consumer Information (Wolters Kluwer)
• Estradiol Valerate Consumer Information (Wolters Kluwer)
• Estradiol Weekly Patch Consumer Information (Wolters Kluwer)
• Estring Ring Consumer Information (Wolters Kluwer)
• Estradiol injection Consumer Information (Cerner Multum)
• Estradiol oral Consumer Information (Cerner Multum)
• Estradiol topical for use on skin Consumer Information (Cerner Multum)
• Estradiol transdermal Consumer Information (Cerner Multum)
• Estradiol vaginal Consumer Information (Cerner Multum)
• Estradiol AHFS DI Monographs (ASHP)

Bioclavid

Bioclavid may be available in the countries listed below.

Ingredient matches for Bioclavid

Amoxicillin

Amoxicillin is reported as an ingredient of Bioclavid in the following countries:

• Poland

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Bioclavid in the following countries:

• Argentina


• Denmark


• Finland


• Greece


• Philippines


• Romania


• Sweden

Clavulanate

Clavulanic Acid is reported as an ingredient of Bioclavid in the following countries:

• Poland

Clavulanic Acid potassium (a derivative of Clavulanic Acid) is reported as an ingredient of Bioclavid in the following countries:

• Argentina


• Denmark


• Finland


• Greece


• Philippines


• Romania


• Sweden

International Drug Name Search

Calmac

Calmac may be available in the countries listed below.

Ingredient matches for Calmac

Epalrestat

Epalrestat is reported as an ingredient of Calmac in the following countries:

• Japan

International Drug Name Search

Codipar Plus

Codipar Plus may be available in the countries listed below.

Ingredient matches for Codipar Plus

Caffeine

Caffeine is reported as an ingredient of Codipar Plus in the following countries:

• Poland

Paracetamol

Paracetamol is reported as an ingredient of Codipar Plus in the following countries:

• Poland

International Drug Name Search